Robert Schmouder

Title: The Innovations of Robert Schmouder

Introduction

Robert Schmouder is an accomplished inventor based in Berkeley Heights, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and other inflammatory disorders. With a total of 2 patents, his work has the potential to impact patient care and treatment protocols.

Latest Patents

Schmouder's latest patents focus on dosage regimens of S1P receptor modulators. The first patent addresses a regimen for treating patients suffering from multiple sclerosis. It emphasizes the importance of testing patients for a history of infection caused by the varicella zoster virus and ensuring they are vaccinated before administering the S1P receptor modulator or agonist. The second patent also pertains to dosage regimens for S1P receptor modulators in treating inflammatory or autoimmune disorders, specifically highlighting the administration of fingolimod at a daily dosage of 0.5 mg after appropriate patient testing and vaccination.

Career Highlights

Throughout his career, Robert Schmouder has worked with notable companies, including Novartis AG. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of drug development and patient treatment.

Collaborations

Schmouder has collaborated with professionals such as Craig Boulton and Pascale Burtin. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert Schmouder's contributions to the field of medicine through his patents on S1P receptor modulators demonstrate his commitment to improving patient outcomes. His work continues to pave the way for advancements in the treatment of multiple sclerosis and other autoimmune disorders.